Wells Fargo’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $415K | Buy |
20,300
+3,953
| +24% | +$80.7K | ﹤0.01% | 3912 |
|
2025
Q1 | $327K | Buy |
16,347
+972
| +6% | +$19.5K | ﹤0.01% | 3941 |
|
2024
Q4 | $410K | Buy |
15,375
+3,460
| +29% | +$92.2K | ﹤0.01% | 3857 |
|
2024
Q3 | $340K | Buy |
11,915
+408
| +4% | +$11.6K | ﹤0.01% | 3864 |
|
2024
Q2 | $251K | Buy |
11,507
+2,081
| +22% | +$45.3K | ﹤0.01% | 4009 |
|
2024
Q1 | $209K | Buy |
9,426
+1,479
| +19% | +$32.8K | ﹤0.01% | 4084 |
|
2023
Q4 | $171K | Buy |
7,947
+1,546
| +24% | +$33.4K | ﹤0.01% | 4171 |
|
2023
Q3 | $108K | Sell |
6,401
-5,011
| -44% | -$84.6K | ﹤0.01% | 4400 |
|
2023
Q2 | $157K | Buy |
11,412
+5,578
| +96% | +$76.5K | ﹤0.01% | 4480 |
|
2023
Q1 | $133K | Sell |
5,834
-18,247
| -76% | -$415K | ﹤0.01% | 4400 |
|
2022
Q4 | $567K | Buy |
24,081
+19,979
| +487% | +$470K | ﹤0.01% | 3350 |
|
2022
Q3 | $107K | Buy |
4,102
+838
| +26% | +$21.9K | ﹤0.01% | 4275 |
|
2022
Q2 | $71K | Sell |
3,264
-101,099
| -97% | -$2.2M | ﹤0.01% | 4581 |
|
2022
Q1 | $4.68M | Sell |
104,363
-3,359
| -3% | -$151K | ﹤0.01% | 2369 |
|
2021
Q4 | $4.62M | Sell |
107,722
-462,813
| -81% | -$19.8M | ﹤0.01% | 2504 |
|
2021
Q3 | $37.9M | Buy |
570,535
+62,997
| +12% | +$4.19M | 0.01% | 1200 |
|
2021
Q2 | $37.2M | Sell |
507,538
-6,353
| -1% | -$466K | 0.01% | 1227 |
|
2021
Q1 | $35.2M | Sell |
513,891
-77,215
| -13% | -$5.29M | 0.01% | 1222 |
|
2020
Q4 | $39.7M | Sell |
591,106
-12,425
| -2% | -$834K | 0.01% | 1111 |
|
2020
Q3 | $31.1M | Buy |
603,531
+46,058
| +8% | +$2.37M | 0.01% | 1126 |
|
2020
Q2 | $21M | Buy |
557,473
+296,960
| +114% | +$11.2M | 0.01% | 1335 |
|
2020
Q1 | $7.77M | Buy |
260,513
+254,404
| +4,164% | +$7.58M | ﹤0.01% | 1845 |
|
2019
Q4 | $210K | Buy |
6,109
+2,510
| +70% | +$86.3K | ﹤0.01% | 4770 |
|
2019
Q3 | $65K | Buy |
+3,599
| New | +$65K | ﹤0.01% | 5211 |
|